Reportbuyer.com just published a new market research report: . London (PRWEB) November 04, 2013 PharmaPoint: Non-Small Cell Lung Cancer - India... ...http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=76067
New research suggests that the investigational drug AZD9291, a third-generation EGFR inhibitor, showed promise in preclinical studies in treating... ...http://www.medindia.net/news/potential-new-drug-for-treatment-resistant-lung-cancer-shows-promise-in-preclinical-studies-126694-1.htm
The study is published this week in the journal CPT: Pharmacometrics & Systems Pharmacology. Microarray-based technologies are widely used to... ...http://webnewswire.com/node/3532640
Study Published in Nature Is First Showing Exomes Sequenced from Patients'' Plasma Can Serve as Non-Invasive Biopsy to Track Evolution of... ...http://www.asianhhm.com/news/news_archives.asp?NewsID=53341&title=Utility-Of-Rubicon-Genomics-ThruPLEX™FD-Kit-Validated-In-Study-Showing-quotLiquid-Biopsyquot-Can-Track-Genomic-Evolution-Of-Cancer-In-Response-To-Therapy
Gefitinib, Erlonat, Veenat, Sorafenib.